1-14 of 14 results for subject:Pfizer
Librarians' tools
- Search time
- 0.197 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
Primary member
Answering member
More
Legislative stage
Legislation
Subject
Publisher
First of all, may I welcome the fact that the right hon. Gentleman has welcomed the fall in unemployment? These are, of course, jobs that he predicted would never come to Britain and would never be there. This is important, because what we see today is the largest-ever quarterly increase in the number of people in work—283,000. We see unemployment coming down, youth unemployment coming down, long-term unemployment coming down, and long-term youth unemployment coming down—and of course, in our growing economy, where our long-term economic plan is working, we see the number of vacancies going up. Hon. Members may be interested to know, in addition, that three quarters of the new jobs over the last year have gone to UK nationals, and also that the employment of Romanians and Bulgarians actually went down in the first three months of this year following the lifting of the controls, which is notable.
In terms of Pfizer and AstraZeneca, this Government have been absolutely clear that the right thing to do is to get stuck in to seek the best possible guarantees on British jobs, British investment and British science. We discussed this last week and one of the most important things we have learned since then is that the right hon. Gentleman was asked for a meeting with Pfizer, but he said he was too busy political campaigning. He quite literally put party politics ahead of the national interest.
First of all, may I welcome the fact that the right hon. Gentleman has welcomed the fall in unemployment? These are, of course, jobs that he predicted would never come to Britain and would never be there. This is important, because what we see today is the largest-ever quarterly increase in the number of people in work—283,000. We see unemployment coming down, youth unemployment coming down, long-term unemployment coming down, and long-term youth unemployment coming down—and of course, in our growing economy, where our long-term economic plan is working, we see the number of vacancies going up. Hon. Members may be interested to know, in addition, that three quarters of the new jobs over the last year have gone to UK nationals, and also that the employment of Romanians and Bulgarians actually went down in the first three months of this year following the lifting of the controls, which is notable.
In terms of Pfizer and AstraZeneca, this Government have been absolutely clear that the right thing to do is to get stuck in to seek the best possible guarantees on British jobs, British investment and British science. We discussed this last week and one of the most important things we have learned since then is that the right hon. Gentleman was asked for a meeting with Pfizer, but he said he was too busy political campaigning. He quite literally put party politics ahead of the national interest.
I welcome the fall in unemployment. For all those people who have found work, it is good for them and good for their families.
On the subject of high-skilled jobs in the UK, following the appearance of Pfizer at the Select Committee yesterday, can the Prime Minister tell us what further assurances he is seeking from Pfizer about its takeover of AstraZeneca?
We want the strongest possible guarantees, but I have to ask the right hon. Gentleman: what is the way of getting those guarantees? Is it getting stuck in with Pfizer and AstraZeneca, battling for the British interest, or is it standing back like him, doing absolutely nothing apart from playing politics? That is the point I put to him. I am clear about what the British interest is: it is British jobs, British science and British R and D, and we will do everything we can to make those guarantees that we have received—the right hon. Gentleman would have got nothing—as firm as possible. As we do so, let us remember that 175,000 people are employed in the life sciences in our country, because we are an open economy that encourages investment. Eli Lilly, Novartis, Johnson & Johnson and e Sci have chosen to come and invest here because it is a great country to come and do business.
We want the strongest possible guarantees, but I have to ask the right hon. Gentleman: what is the way of getting those guarantees? Is it getting stuck in with Pfizer and AstraZeneca, battling for the British interest, or is it standing back like him, doing absolutely nothing apart from playing politics? That is the point I put to him. I am clear about what the British interest is: it is British jobs, British science and British R and D, and we will do everything we can to make those guarantees that we have received—the right hon. Gentleman would have got nothing—as firm as possible. As we do so, let us remember that 175,000 people are employed in the life sciences in our country, because we are an open economy that encourages investment. Eli Lilly, Novartis, Johnson & Johnson and e Sci have chosen to come and invest here because it is a great country to come and do business.
I am not going to take any lectures from the guy who was negotiating with Pfizer over the heads of the board of AstraZeneca. Pfizer does not need a public relations man—it has the Prime Minister.
For Members on both sides of the House, the appearance of Pfizer at a Select Committee raised more questions than it answered about the so-called assurances. The head of Pfizer said there would be a fall in research and development spending as a result of the takeover. Has the Prime Minister got an assurance that those R and D cuts will not take place in the UK?
We have assurances on the percentage of R and D that will happen here and on investment in Cambridge and in Macclesfield. If the right hon. Gentleman is asking whether we want further assurances, then yes, we do. Do we want to make sure those jobs stay here? Yes, we do. Do we want more investment in British universities and British science? Yes, we do. The only difference between us is on how to get those things. I say: get stuck in, negotiate hard and fight for Britain. He says: stand up, play politics and put that before the national interest.
We have assurances on the percentage of R and D that will happen here and on investment in Cambridge and in Macclesfield. If the right hon. Gentleman is asking whether we want further assurances, then yes, we do. Do we want to make sure those jobs stay here? Yes, we do. Do we want more investment in British universities and British science? Yes, we do. The only difference between us is on how to get those things. I say: get stuck in, negotiate hard and fight for Britain. He says: stand up, play politics and put that before the national interest.
The problem is that the assurances are “vague”, have “caveats” and are “inappropriate”. Those are not my words, but the words of the president of the Royal Society. The assurances are useless and there is no guarantee on R and D.
Let us talk about jobs. The head of Pfizer said yesterday:
“There will be job cuts somewhere”.
Has the Prime Minister got an assurance that those job cuts will not take place in the UK?
What we want is a good outcome for British investment and British jobs. We know what happens if you take the approach of the Labour party. Let us remember Kraft and Cadbury. What did we have? We had outright opposition, wonderful speeches about blocking investment and then complete and abject surrender and the closure of plants under Labour. That is what happened. We have learned the lessons of the mistakes Labour made. We are operating under the framework that it left us—which, incidentally, the right hon. Gentleman wrote when he was at the Treasury—and we will get results for British science, British jobs and investment by being engaged rather than standing off and playing politics.
What we want is a good outcome for British investment and British jobs. We know what happens if you take the approach of the Labour party. Let us remember Kraft and Cadbury. What did we have? We had outright opposition, wonderful speeches about blocking investment and then complete and abject surrender and the closure of plants under Labour. That is what happened. We have learned the lessons of the mistakes Labour made. We are operating under the framework that it left us—which, incidentally, the right hon. Gentleman wrote when he was at the Treasury—and we will get results for British science, British jobs and investment by being engaged rather than standing off and playing politics.
But the Prime Minister’s negotiations are not working—they are worthless. On R and D and jobs, he has no answer.
Let us try the Prime Minister on another issue: the possible carving up of the merged company. Nobody wants the company to be bought, split up and then sold off. Has he got assurances that that will not happen in the case of this takeover?
Once again, the right hon. Gentleman raises this issue about the public interest test. It is worth asking which party, which Government and indeed which individual, when he was sitting in the Treasury writing the rules, got rid of that test. It was the right hon. Gentleman. That is what we see: on a day when unemployment is down, on a day when more people are in work, he will try any trick other than to talk about what is happening in our economy. That is the truth. The country is getting stronger, and he is getting weaker.
Once again, the right hon. Gentleman raises this issue about the public interest test. It is worth asking which party, which Government and indeed which individual, when he was sitting in the Treasury writing the rules, got rid of that test. It was the right hon. Gentleman. That is what we see: on a day when unemployment is down, on a day when more people are in work, he will try any trick other than to talk about what is happening in our economy. That is the truth. The country is getting stronger, and he is getting weaker.
We all know what happened the last time the Prime Minister got assurances: he sold off Royal Mail at a knock-down price and the Chancellor’s best man made a killing. That is what happens with the Prime Minister’s assurances.
The truth is that the Prime Minister cannot give us a guarantee, because the chief executive says that he wants to “conserve the optionality” of splitting up the company and flogging it off. Last week, the Prime Minister said he would judge the takeover on
“British jobs, British investment and British science.”—[Official Report, 7 May 2014; Vol. 580, c. 146.]
But he cannot offer us assurances on any of those things. Is it not obvious—he should have a proper test of the public interest, and if the deal does not pass, he should block it?
If the right hon. Gentleman thinks these companies are important, why did he not meet them, rather than going canvassing? That is what he did: he quite literally put his own party political interest ahead of the national interest. What he fails to understand is that, yes, we measure the British interest in British jobs, British science and British investment, but we also measure it in being a country that is open to overseas investment. There is a reason why companies and countries are coming here to make cars, to build aeroplanes, to build trains, to fabricate oil rigs, to make new drugs in our country—it is because we have cut taxes, we welcome investment, we are growing our economy and we have got more people in work. We will take absolutely no lectures from the people who brought this economy to its knees.
If the right hon. Gentleman thinks these companies are important, why did he not meet them, rather than going canvassing? That is what he did: he quite literally put his own party political interest ahead of the national interest. What he fails to understand is that, yes, we measure the British interest in British jobs, British science and British investment, but we also measure it in being a country that is open to overseas investment. There is a reason why companies and countries are coming here to make cars, to build aeroplanes, to build trains, to fabricate oil rigs, to make new drugs in our country—it is because we have cut taxes, we welcome investment, we are growing our economy and we have got more people in work. We will take absolutely no lectures from the people who brought this economy to its knees.
The Prime Minister might not think it important to talk about a company that is 2% of UK exports and on which 30,000 jobs depend. It is important: it is crucial to our national interest. The truth is that he is not powerless. He is the Prime Minister, and he could act on a public interest test. We are talking about one of our most important companies. Nobody is convinced by his assurances. Why will he not intervene? Because he is falling back on the old idea that the market always knows best and does not need rules. From Royal Mail to AstraZeneca, this is a Prime Minister whose ideology means that he cannot stand up for the national interest.
As I explained to the right hon. Member for Doncaster North (Edward Miliband), we are operating under the legal framework that was put in place by the Government of whom he was a member. When the hon. Gentleman looks at the record of what was said yesterday, I think he will find that the quotes that he has given are not accurate.
As I explained to the right hon. Member for Doncaster North (Edward Miliband), we are operating under the legal framework that was put in place by the Government of whom he was a member. When the hon. Gentleman looks at the record of what was said yesterday, I think he will find that the quotes that he has given are not accurate.
Q5
.
Kevin Brennan (Cardiff West) (Lab):
The Pfizer boss did give assurances to the Business, Innovation and Skills Committee yesterday. He gave an absolute assurance that any takeover of AstraZeneca would result in a fall in research and development in its new drugs in the UK. He gave an absolute assurance that it would result in a fall in UK jobs. The AstraZeneca boss said that it could put lives at risk. How could any Prime Minister worth the title not immediately conclude that the right thing to do in the national interest is to call this in?
(2) what discussions either orally or in writing he or his Ministers or officials have had with (a) Pfizer and (b) AstraZeneca in the last two months regarding any bid for AstraZeneca.
Ann McKechin:
(2) what discussions either orally or in writing he or his Ministers or officials have had with (a) Pfizer and (b) AstraZeneca in the last two months regarding any bid for AstraZeneca.
Ann McKechin:
We are committed to ensuring that the life sciences sector in this country continues to flourish and grow, with the UK at the forefront of life sciences R and D, and retaining our role as a leading manufacturing base. While ultimately the potential takeover bid is a matter for the respective boards and shareholders of the two companies, Ministers and officials across Government have engaged with both companies to ensure that the outcome is positive for the long-term future of this sector in the UK.
I also refer the hon. Member to the answers I gave at Prime Minister’s Questions today.
I absolutely agree with what the Business Secretary said yesterday, but let me be clear that the most important intervention we can make is to back British jobs, British science, British research and
development, British medicines and British technology. That is why I asked the Cabinet Secretary and my Ministers to engage with both companies right from the start of this process, and I make no apology for that, because we know what happens when you do not engage. If you stand back and just say you are opposed to everything, you get abject surrender and no guarantees for Britain. We are fighting for British science, and it is a pity that the right hon. Gentleman is trying to play politics rather than backing the national interest.
I absolutely agree with what the Business Secretary said yesterday, but let me be clear that the most important intervention we can make is to back British jobs, British science, British research and
development, British medicines and British technology. That is why I asked the Cabinet Secretary and my Ministers to engage with both companies right from the start of this process, and I make no apology for that, because we know what happens when you do not engage. If you stand back and just say you are opposed to everything, you get abject surrender and no guarantees for Britain. We are fighting for British science, and it is a pity that the right hon. Gentleman is trying to play politics rather than backing the national interest.
There is deep concern in the British business and scientific communities about the proposed takeover of AstraZeneca by Pfizer. The deal would have an impact for decades to come on British jobs, British investment, British exports and British science. The Business Secretary said yesterday that he is “not ruling out intervention”. What type of intervention is under consideration by Government?
The assessment that I want is from the Business Department on this deal or indeed, because there is not now an actual offer on the table, any subsequent offer. I will judge all these things on whether they expand British jobs, British investment and British science. Let me just make this point, because I worry that it may be lost in this debate. We all know that the right hon. Gentleman thinks he is extremely clever—we all know that—but he may have missed this point. Britain benefits massively from being open to investment. Nissan is now producing more cars than the whole of Italy. Jaguar Land Rover, under Indian ownership, has created 9,000 jobs in the west midlands since I became Prime Minister. Vodafone and indeed AstraZeneca have benefited from that backing of an open country to go out and build and buy businesses around the world. There is more inward investment in Britain today than the rest of the EU combined. Let us not put that at risk.
The assessment that I want is from the Business Department on this deal or indeed, because there is not now an actual offer on the table, any subsequent offer. I will judge all these things on whether they expand British jobs, British investment and British science. Let me just make this point, because I worry that it may be lost in this debate. We all know that the right hon. Gentleman thinks he is extremely clever—we all know that—but he may have missed this point. Britain benefits massively from being open to investment. Nissan is now producing more cars than the whole of Italy. Jaguar Land Rover, under Indian ownership, has created 9,000 jobs in the west midlands since I became Prime Minister. Vodafone and indeed AstraZeneca have benefited from that backing of an open country to go out and build and buy businesses around the world. There is more inward investment in Britain today than the rest of the EU combined. Let us not put that at risk.
It is good to hear that the right hon. Gentleman agrees with the Business Secretary. The Business Secretary said this:
“One of the Government’s options would be to consider using our public interest test powers.”—[Official Report, 6 May 2014; Vol. 580, c. 23.]
There needs to be a proper assessment of this bid, and yesterday the Business Secretary said that he was open to doing that. It could be done straight away, through this House, and we on the Labour Benches would support making that happen. Will the Prime Minister agree to do it?
I think it is deeply sad that the Leader of the Opposition makes accusations about cheerleading when the Government were getting stuck in to help British science, British investment and British jobs. Does it not tell us everything that, given the choice of doing the right thing for the national interest and working with the Government or making short-term political points, that is what he chooses to do? We might ask why the public interest test was changed in the first place. It happened when they were sitting in the Treasury. Yes, they wrote the rules, they sold the gold and they
saw manufacturing in our country decline by one half. We will never take lectures from the people who wrecked our economy.
I think it is deeply sad that the Leader of the Opposition makes accusations about cheerleading when the Government were getting stuck in to help British science, British investment and British jobs. Does it not tell us everything that, given the choice of doing the right thing for the national interest and working with the Government or making short-term political points, that is what he chooses to do? We might ask why the public interest test was changed in the first place. It happened when they were sitting in the Treasury. Yes, they wrote the rules, they sold the gold and they
saw manufacturing in our country decline by one half. We will never take lectures from the people who wrecked our economy.
The right hon. Gentleman does not understand. This is simply about something very straightforward—having an independent assessment of this bid and whether it is in the national interest. I will ask him the question again as it matters to people right across this country. Is he ruling out, or ruling in, using the public interest test on this takeover? We could make it happen. His Business Secretary could make it happen, and we would support it. If he does not take action now, and the bid goes through without a proper assessment, everyone will know that he was cheerleading for this bid, not championing British science and British industry.
I am grateful for my hon. Friend’s remarks. There are 2,000 people employed by AstraZeneca in his constituency, and he is quite right to speak up for them. Our entire approach is based on trying to secure the best possible deal in terms of jobs, investment and science, and that is why I believe it was absolutely right
to ask the Cabinet Secretary to engage with Pfizer, just as we are engaging with AstraZeneca. I find it extraordinary that we have been criticised for this. Of course, there is no offer on the table, but the commitments that have been made so far are encouraging in terms of completing the Cambridge campus and making sure that 20% of the combined companies’ total research and development work force is in the UK going forward—and they specifically mention substantial commercial manufacturing facilities in Macclesfield. The company also goes on to say that because of the patent box that we have introduced, it would look at manufacturing more in the UK. But let me absolutely clear: I am not satisfied; I want more, but the way to get more is to engage, not to stand up and play party politics.
I am grateful for my hon. Friend’s remarks. There are 2,000 people employed by AstraZeneca in his constituency, and he is quite right to speak up for them. Our entire approach is based on trying to secure the best possible deal in terms of jobs, investment and science, and that is why I believe it was absolutely right
to ask the Cabinet Secretary to engage with Pfizer, just as we are engaging with AstraZeneca. I find it extraordinary that we have been criticised for this. Of course, there is no offer on the table, but the commitments that have been made so far are encouraging in terms of completing the Cambridge campus and making sure that 20% of the combined companies’ total research and development work force is in the UK going forward—and they specifically mention substantial commercial manufacturing facilities in Macclesfield. The company also goes on to say that because of the patent box that we have introduced, it would look at manufacturing more in the UK. But let me absolutely clear: I am not satisfied; I want more, but the way to get more is to engage, not to stand up and play party politics.
Q7
.
David Rutley (Macclesfield) (Con):
AstraZeneca is Macclesfield’s largest employer with 2,000 employees, so I share constituents’ concerns about Pfizer’s proposed bid. I welcome the steps taken by the Government to secure initial commitments from the company if it succeeds. Can the Prime Minister tell the House what further steps are being taken to strengthen those commitments and to safeguard highly skilled manufacturing jobs in Macclesfield?
As I said, the more we can do to strengthen the assurances we are given, the better. But the only way to get assurances is by engaging and getting stuck in with those companies, which is what we have been doing, and I find it extraordinary that the Labour party chooses to criticise us for that.
As I said, the more we can do to strengthen the assurances we are given, the better. But the only way to get assurances is by engaging and getting stuck in with those companies, which is what we have been doing, and I find it extraordinary that the Labour party chooses to criticise us for that.
Yesterday, the Secretary of State for Business, Innovation and Skills said that he was working with civil servants to ensure that any assurances given by Pfizer during the proposed takeover of AstraZeneca could be made legally binding. Does the Prime Minister back that?
In its letter to me, Pfizer mentions the patent box as a positive reason for wanting to invest in Britain and for examining whether it could increase manufacturing in Britain. Of course, because of the way the patent box works, you only get the low-tax benefit if you make your investments and do research in the UK, and then exploit that research by manufacturing in the UK. I agree with the hon. Gentleman that we should be incredibly hard-headed about this. It is an advantage that Britain is a low-tax country. We used to stand in this House of Commons and bemoan the fact that companies were leaving because of our high taxes. They now want to come here because of our tax system. I agree with the Business Secretary that that is not enough; we want the investment, the jobs and the research that comes with that competitive tax system.
In its letter to me, Pfizer mentions the patent box as a positive reason for wanting to invest in Britain and for examining whether it could increase manufacturing in Britain. Of course, because of the way the patent box works, you only get the low-tax benefit if you make your investments and do research in the UK, and then exploit that research by manufacturing in the UK. I agree with the hon. Gentleman that we should be incredibly hard-headed about this. It is an advantage that Britain is a low-tax country. We used to stand in this House of Commons and bemoan the fact that companies were leaving because of our high taxes. They now want to come here because of our tax system. I agree with the Business Secretary that that is not enough; we want the investment, the jobs and the research that comes with that competitive tax system.
Yesterday, the Secretary of State for Business, Innovation and Skills said that he was working with civil servants to ensure that any assurances given by Pfizer during the proposed takeover of AstraZeneca could be made legally binding. Does the Prime Minister back that?